Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nehal Lakhani, MD
START Midwest
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
- Centre Georges-François Leclerc, Department of Medical Oncology
Dijon, France
- Institut de Cancerologie de L'Ouest
Saint-Herblain, France
- Vall D'Hebron Institute of Oncology
Barcelona, Spain
- Hospital Universitario San Carlos
Madrid, Spain
- University of Colorado
Aurora, Colorado, United States
- Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- University of Chicago
Chicago, Illinois, United States
- University of Kansas Medical Center (kumc)
Westwood, Kansas, United States
- Start Midwest
Grand Rapids, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Mount Sinai - Prime
New York, New York, United States
- Montefiore Medical Center Prime
The Bronx, New York, United States
- University of Cincinnati Medical Center
Cincinnati, Ohio, United States
- Md Anderson
Houston, Texas, United States
- Virginia Cancer Specialists, Pc
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Oct 2020
- Primary completion
- 3 Jun 2024
- Completion
- 3 Jun 2024
- Last update posted
- 26 Jun 2024
- Registered enrollment
- 78
- Registry id
- NCT04641871
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.